CHANTILLY, Va.--(BUSINESS WIRE)--Engility Holdings, Inc. (NYSE:EGL), today announced it was awarded a $112 million single-award indefinite delivery/indefinite quantity (IDIQ) contract by the Food and Drug Administration (FDA) Scientific Computing Board and Office of Information Management and Technology (OIMT). Engility will deliver services unique to computational science and bioinformatics, a discipline that promotes gene-based drug discovery and development.
“With this award, Engility expands on our long-standing partnership with the FDA to further develop their high performance computing and complex data analysis capabilities,” said Engility CEO Lynn Dugle. “We look forward to supporting the FDA’s mission to make groundbreaking treatments, such as genetics-based medicine, available to all Americans.”
As part of the OIMT contract, the Engility team will provide security, operations and maintenance, and technical support for scientific computing environments and systems. Engility will help the FDA build fast, reliable and adaptable high performance computing architectures that accommodate analyses of complex data sets. These capabilities are critical to answer FDA’s front-line needs, such as rapid genomics analyses that address emerging threats to America’s food supply and adverse event studies of new personalized medicine therapies.
The services Engility provides under the contract will enable better insights through faster, better-informed regulatory decisions and secure collaboration among FDA scientists and the worldwide scientific community. Engility will work with the Office of Acquisition & Grants Services, FDA Centers and OIMT leadership to apply scientific computing to regulatory-science innovations.
The 5-year award, made in the third quarter of 2016, more than doubles the predecessor $50 million scientific computing IDIQ, where Engility was also the sole holder. The expanded scope signals an increased reliance on scientific computing as an enabler for FDA’s mission.
About Engility
Engility Holdings, Inc. (NYSE: EGL), a leading provider of mission-critical and highly technical services to the U.S. government, is engineered to make a difference. Built on a five-decade commitment to our customers and our country, Engility delivers world-class performance, efficiency and value in a broad range of services, including engineering and technology life cycle support, program and business support and specialized technical consulting. Headquartered in Chantilly, Virginia, and with offices around the world, Engility supports customers throughout the defense, intelligence, space, federal civilian and international communities, drawing on our intimate understanding of customer needs, our deep domain expertise and our highly skilled employees to develop and deliver on-target solutions. To learn more about Engility, please visit www.engilitycorp.com and connect with us on Facebook, LinkedIn and Twitter.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Engility’s future prospects, projected financial results, estimated integration costs and acquisition related amortization expenses, business plans, as well as the TASC transaction and its expected benefits and the timing of such benefits. Words such as "may," "will," "should," "likely," "anticipates," "expects," "intends," "plans," "projects," "believes," "estimates" and similar expressions are also used to identify these forward-looking statements. These statements are based on the current beliefs and expectations of Engility’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Factors that could cause Engility’s actual results to differ materially from those described in the forward-looking statements can be found under the heading "Risk Factors" included in our Annual Report on Form 10-K for the year ended December 31, 2015, and more recent documents that have been filed with the Securities and Exchange Commission (SEC) and are available on the investor relations section of Engility’s website (http://www.engilitycorp.com) and on the SEC’s website (www.sec.gov). Forward-looking statements are made only as of the date hereof, and we undertake no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, historical information should not be considered as an indicator of future performance.
